Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cMet antibody drug conjugates and methods for their use

Anti-cMet antibody drug conjugates and methods for their use

US Patent 10383948 · Granted Aug 20, 2019

Estimated economic value: $652,026,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR and C-met fibronectin type III domain binding molecules2025
Therapeutic agents and methods for enhancing immune responses in tumor microenvi2024
Anti-CD40 antibodies and uses thereof2024
Anti-c-Met antibody drug conjugates2023
Anti-CD137 antibodies and uses thereof2022
Humanized anti-CD137 antibodies and uses thereof2021
Anti-CD40 antibody having engineered Fc domains and therapeutic uses thereof2021
Stabilized liquid anti-RSV antibody formulations2021
EGFR and c-Met fibronectin type III domain binding molecules2021
Anti-PD-1 antibodies and therapeutic uses thereof2021
Anti-4-1BB antibodies and their uses2020
Cysteine engineered fibronectin type III domain binding molecules2020